Skip to main content

Table 3 Outcome analysis comparing empiric β-lactam versus vancomycin, adjusted for age, age-adjusted Charlson-comorbidity index, infectious diseases consultation, infective endocarditis and time to receipt of empiric antibiotics

From: Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia

Outcomes Crude OR (95 % CI) p value Adjusted OR (95 % CI) p value
28-day mortality 0.60 (0.23–1.55) 0.29 0.85 (0.27–2.67) 0.78
90-day mortality 0.56 (0.28–1.15) 0.11 0.88 (0.36–2.17) 0.79
  Ratio of mean (95 % CI) p value Adjusted ratio of mean (95 % CI) p value
Duration of bacteremia 0.77 (0.64–0.93) 0.01 0.77 (0.62–0.95) 0.01
Hospital length-of-stay 0.85 (0.68–1.07) 0.16 0.86 (0.66–1.10) 0.23
  1. Duration of bacteremia was further adjusted for surgical source control
  2. OR odds ratio, CI confidence interval